In contrast, only about ten studies have examined the pro-tumor effects of EFEMP1, comprising only five tumor types (pancreatic carcinoma, glioma, cervical cancer, ovarian carcinoma and pleural mesothelioma). This evidence concerns the gene EFEMP1 and exocrine pancreatic carcinoma.